BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29125826)

  • 1. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.
    Tjin G; White ES; Faiz A; Sicard D; Tschumperlin DJ; Mahar A; Kable EPW; Burgess JK
    Dis Model Mech; 2017 Nov; 10(11):1301-1312. PubMed ID: 29125826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
    Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
    Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction.
    González-Santamaría J; Villalba M; Busnadiego O; López-Olañeta MM; Sandoval P; Snabel J; López-Cabrera M; Erler JT; Hanemaaijer R; Lara-Pezzi E; Rodríguez-Pascual F
    Cardiovasc Res; 2016 Jan; 109(1):67-78. PubMed ID: 26260798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
    Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
    PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis.
    Luzina IG; Lockatell V; Hyun SW; Kopach P; Kang PH; Noor Z; Liu A; Lillehoj EP; Lee C; Miranda-Ribera A; Todd NW; Goldblum SE; Atamas SP
    Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L940-54. PubMed ID: 26993524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
    Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
    Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts.
    Nizamoglu M; Alleblas F; Koster T; Borghuis T; Vonk JM; Thomas MJ; White ES; Watson CK; Timens W; El Kasmi KC; Melgert BN; Heijink IH; Burgess JK
    Acta Biomater; 2024 Mar; 177():118-131. PubMed ID: 38350556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
    Craig VJ; Zhang L; Hagood JS; Owen CA
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs.
    Kumarasamy A; Schmitt I; Nave AH; Reiss I; van der Horst I; Dony E; Roberts JD; de Krijger RR; Tibboel D; Seeger W; Schermuly RT; Eickelberg O; Morty RE
    Am J Respir Crit Care Med; 2009 Dec; 180(12):1239-52. PubMed ID: 19797161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.
    Nkyimbeng T; Ruppert C; Shiomi T; Dahal B; Lang G; Seeger W; Okada Y; D'Armiento J; Günther A
    PLoS One; 2013; 8(9):e73279. PubMed ID: 24023851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta.
    Behmoaras J; Slove S; Seve S; Vranckx R; Sommer P; Jacob MP
    Rejuvenation Res; 2008 Oct; 11(5):883-9. PubMed ID: 18803461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
    Fujimoto E; Tajima S
    J Dermatol Sci; 2009 Aug; 55(2):91-8. PubMed ID: 19394199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysyl Oxidase Activity Is Required for Ordered Collagen Fibrillogenesis by Tendon Cells.
    Herchenhan A; Uhlenbrock F; Eliasson P; Weis M; Eyre D; Kadler KE; Magnusson SP; Kjaer M
    J Biol Chem; 2015 Jun; 290(26):16440-50. PubMed ID: 25979340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of caveolin-1 and extracellular matrix in lung tissues of patients with idiopathic pulmonary fibrosis].
    Wang XF; Ding H; Zhou FQ; Meng FQ; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):336-9. PubMed ID: 22883991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
    Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.
    Staab-Weijnitz CA; Fernandez IE; Knüppel L; Maul J; Heinzelmann K; Juan-Guardela BM; Hennen E; Preissler G; Winter H; Neurohr C; Hatz R; Lindner M; Behr J; Kaminski N; Eickelberg O
    Am J Respir Crit Care Med; 2015 Aug; 192(4):455-67. PubMed ID: 26039104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation.
    Gayathri R; Coral K; Sharmila F; Sripriya S; Sripriya K; Manish P; Shantha B; Ronnie G; Vijaya L; Narayanasamy A
    Curr Eye Res; 2016 Oct; 41(10):1331-1338. PubMed ID: 27116380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.